Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
-
Information for professionals for Vannair 100/6
-
Änderungen
-
12.06.2021
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
4 Änderungen an Fachinfo Vannair 100/6
-
Häufig: oropharyngealer Candida-Infekt (Soor).
+
Häufig: oropharyngealer Candida-Infekt (Soor)
, Pneumonie (bei COPD Patienten)
.
-
Juli
2020.
+
Dezember
2020.
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
